Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease

Project Information

EDC-MASLD

Grant agreement ID: 101136259

DOI

10.3030/101136259

EC signature date 10 November 2023

Start date 1 January 2024

End date 31 December 2028

Funded under

• Health

Total cost

€ 7 053 942,75

EU contribution

€ 7 053 942,75

Coordinated by

OREBRO UNIVERSITY
Sweden

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models

Author(s): Andi Alijagic, Lisanna Sinisalu, Daniel Duberg, Oleksandr Kotlyar, Nikolai Scherbak, Magnus Engwall, Matej Orešič, Tuulia Hyötyläinen
Published in: Environment International, Issue 190, 2024, ISSN 0160-4120
Publisher: Elsevier BV
DOI: 10.1016/J.ENVINT.2024.108820

Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies

Author(s): Eleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, Chiara Rosso, Elisabetta Bugianesi
Published in: Nutrients, Issue 17, 2025, ISSN 2072-6643
Publisher: MDPI AG
DOI: 10.3390/nu17030477